Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combined kidney and bone marrow transplantation to induce kidney tolerance in haploidentical donor-recipient pairs
MOH_2021-07-20_010159Phase 2Not yet recruiting
- Sponsor
- ד"ר משה ישורון
- Start
- Jun 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fludarabine in chronic kidney disease (CKD), sponsored by ד"ר משה ישורון. Planned start Jun 2021; status: not yet recruiting.
02
Drugs
fludarabine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on MOH_2021-07-20_010159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-07-20_010159.